Fibroblast growth factor receptor signalling dysregulation and targeting in breast cancer
Name:
Francavilla.pdf
Size:
1.600Mb
Format:
PDF
Description:
Identified with Open Access button
Abstract
Fibroblast Growth Factor Receptor (FGFR) signalling plays a critical role in breast embryonal development, tissue homeostasis, tumorigenesis and metastasis. FGFR, its numerous FGF ligands and signalling partners are often dysregulated in breast cancer progression and are one of the causes of resistance to treatment in breast cancer. Furthermore, FGFR signalling on epithelial cells is affected by signals from the breast microenvironment, therefore increasing the possibility of breast developmental abnormalities or cancer progression. Increasing our understanding of the multi-layered roles of the complex family of FGFRs, their ligands FGFs and their regulatory partners may offer novel treatment strategies for breast cancer patients, as a single agent or rational co-target, which will be explored in depth in this review.Citation
Francavilla C, O’Brien CS. Fibroblast growth factor receptor signalling dysregulation and targeting in breast cancer [Internet]. Vol. 12, Open Biology. The Royal Society; 2022.Journal
Open BiologyDOI
10.1098/rsob.210373Additional Links
https://dx.doi.org/10.1098/rsob.210373Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1098/rsob.210373